ERBB2 and cancer: Alterations in human epidermal growth factor receptor 2 (HER2) expression have been observed in various cancer types, such as those arising in the breast, gastrointestinal tract, urinary bladder, salivary glands, lung, ovaries, colon, and pancreas.